The expanding scope of pharmacists' practice: Implications or physicians

CMAJ. Canadian Medical Association Journal

Volumn 185, Issue 14, 2013, Pages 1228-1232

  Tannenbaum, Cara ^a   Tsuyuki, Ross T ^b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; CYTOCHROME P450; DENOSUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; WARFARIN;

ANTICOAGULANT THERAPY; ASTHMA; CANADA; CARDIOVASCULAR RISK; CHRONIC DISEASE; DIABETES MELLITUS; DRUG INTERACTION; DYSLIPIDEMIA; E-MAIL; ECONOMIC ASPECT; EMERGENCY WARD; ETHICS; FAX; HEALTH CARE NEED; HEALTH PRACTITIONER; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INAPPROPRIATE PRESCRIBING; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; LEGAL LIABILITY; LIFELONG LEARNING; LUNG FUNCTION TEST; MORBIDITY; PATIENT SAFETY; PATIENT SATISFACTION; PHARMACIST; PHYSICIAN; PRESCRIPTION; PREVALENCE; PROFESSIONALISM; REIMBURSEMENT; REVIEW; RISK FACTOR; RISK MANAGEMENT; SCOPE OF PRACTICE; SYSTOLIC BLOOD PRESSURE; TELECONSULTATION; VACCINATION;

EID: 84886393670     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.121990     Document Type: Article

References (46)

1. Summary of pharmacists' expanded scope of practice activities across Canada. Ottawa (ON): Canadian Pharmacists Association; 2013. Available: http://blueprintforpharmacy.ca/docs/kt -tools/pharmacists'-expanded-scope- summary-chart-cpha-june -10 -2013 .pdf (accessed 2013 July 25).
2. Terner M, Reason B, McKeag AM, et al. Chronic conditions more than age drive health system use in Canadian seniors. Healthc Q 2011;14:19-22.
3. National Physician Survey, 2010. Results for family physicians by certification, sex, and age. Mississauga (ON): National Physician Survey; 2010. Available: http://nationalphysiciansurvey.ca/wp-content/uploads/2012/09/2010-FP- Q23.pdf (accessed 2012 Nov. 2).
4. Joint statement on scopes of practice. Ottawa (ON): Canadian Medical Association; 2003. Available: policybase .cma .ca/dbtw -wpd/PolicyPDF/PD03-07. pdf (accessed 2012 Nov. 2).
5. Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract 2011; 19:381-2.
6. Revised pharmacist prescriber scope of practice definition. Wellington (New Zealand): Pharmacy Council of New Zealand; 2011. Available: www.pharmacycouncil .org.nz/cms show-download.php?id=253 (accessed 2012 Nov. 12).
7. McGlew J. Collaborative drug therapy management by state. Lenexa (KS): American College of Clinical Pharmacy; 2012.
8. Seasonal influenza vaccination programme in pharmacies - evidence base and framework. Dublin (Ireland): The Pharmaceutical Society of Ireland.; 2011. Available: www .thepsi .ie/Libraries/Pharmacy-Practice/Final-Seasonal Influenza Vaccination-Programme in-Pharmacies-Evidence Base and Framework .sflb.ashx (accessed 2013 Feb. 26).
9. Francis M, Hinchliffe A. Vaccination services through community pharmacy: a literature review. Cardiff (Wales): Public Health Wales; 2010. Available: www2 .nphs .wales .nhs .uk :8080/Health ServiceQDTDocs.nsf/public/ CBDDC3C0BE9449398025793 B00341 A6F/file/Vaccination%20services %20through %20 community %20pharmacy%20v1a.pdf (accessed 2013 Feb. 26).
10. Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors. Arch Intern Med 2011;171:1441-53.
11. Charrois TL, Zolezzi M, Koshman SL, et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy 2012;32:222-33.
12. Koshman SL, Charrois TL, Simpson SH, et al. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008;168:687-94. (Pubitemid 351563951)
13. Lowrie R, Mair FS, Greenlaw N, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J 2012;33:314-24.
14. Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist- managed anticoagulation clinic: improving patient care. Open Med 2009;3:e16-21.
15. Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009;43:85-97.
16. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008;28:421-36. (Pubitemid 351466454)
17. Evans CD, Watson E, Eurich DT, et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother 2011;45:615-28.
18. Collins C, Limone BL, Scholle JM, et al. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract 2011;92:145-52.
19. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010;(7): CD000336.
20. Cutrona SL, Choudhry NK, Fischer MA, et al. Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care 2010;16:929-42.
21. Charrois TL, McAlister FA, Cooney D, et al. Improving hypertension management through pharmacist prescribing: the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods. Implement Sci 2011;6:94.
22. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178:1563-9. (Pubitemid 351860342)
23. Zakrzewski-Jakubiak H, Doan J, Lamoureux P, et al. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of a new cytochrome P450-based software. Am J Geriatr Pharmacother 2011;9:461-70.
24. Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 2011; 9: 364-77.
25. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12.
26. Smith SM, O'Kelly S, O'Dowd T. GPs' and pharmacists' experiences of managing multimorbidity: a 'Pandora's box.' Br J Gen Pract 2010;60:285-94.
27. Tarn DM, Paterniti DA, Wenger NS, et al. Older patient, physician and pharmacist perspectives about community pharmacists' roles. Int J Pharm Pract 2012;20:285-93.
28. Hatah E, Braund R, Duffull S, et al. General practitioners' perceptions of pharmacists' new services in New Zealand. Int J Clin Pharm 2012;34:364-73.
29. Reason B, Terner M, Moses McKeag A, et al. The impact of polypharmacy on the health of Canadian seniors. Fam Pract 2012; 29:427-32.
30. Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007;32:113-21. (Pubitemid 46449699)
31. Canadian Institute for Health Information. Drug claims by seniors: an analysis focusing on potentially inappropriate medication use, 2000 to 2006. Ottawa (ON): The Institute; 2007. Available: https://secure.cihi.ca/free- products/Potentially-Inappropriate-Medications-EN.pdf (accessed 2012 Aug. 25).
32. Conseil du Médicament. Étude sur la prévalence d l'usage d'ordonnances potentiellement non appropriées (OPNA) chez les ainés du Québec, de 2000 a 2006. Québec (QC): Gouvernement du Québec; 2009. ISBN 978-2-550-55845-3.
33. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
34. Drugs and health products: advisories, warnings and recalls for health professionals. Ottawa (ON): Health Canada; updated 2013. Available: www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/index-eng.php (accessed 2012 Nov. 18).
35. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009;43:1096-106.
36. Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012;28:237-53.
37. Scott IA, Gray LC, Martin JH, et al. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 2012;125:529-37.
38. Schuling J, Gebben H, Veehof LJG, et al. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract 2012;13:56.
39. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997;157:2205-10. (Pubitemid 27451146)
40. CMA code of ethics. Ottawa (ON): The Canadian Medical Association; updated 2004. Available: policybase.cma.ca/dbtw -wpd/PolicyPDF/PD04-06.pdf (accessed 2012 Nov. 18).
41. The new reality: expanding scopes of practice. Ottawa (ON): The Canadian Medical Protective Association; 2010. Available: www .cmpa-acpm.ca/cmpapd04/ docs/member-assistance/more/com p1001 3-e.cfm (accessed 2012 Oct. 1).
42. Collaborative care and medication monitoring: Who's responsible? Ottawa (ON): The Canadian Medical Protective Association; 2008. Available: www.cmpa-acpm .ca/cmpapd04/docs/resource-files/infoletters/2003/com-il0320-1-e .cfm (accessed 2012 Oct. 1).
43. Cranney A. Risk management in elderly patients: medication issues. CMPA Perspective 2011;3:3-5. Available: www.cmpa-acpm .ca/cmpapd04/docs/resource- files/perspective/2011/02/com-p1102-1-e.cfm (accessed 2012 Oct. 1).
44. Liability issues when collaborating with prescribing pharmacists. Ottawa (ON): The Canadian Medical Protective Association; 2009. Available: www.cmpa-acpm .ca/cmpapd04/docs/member-assistance/more/com-p0904-5-e.cfm (accessed 2012 Oct. 1).
45. Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists (SCRIP). Pharmacotherapy 2001;21:627-35. (Pubitemid 32411059)
46. Gallagher RM, Gallagher HC. Improving the working relationship between doctors and pharmacists: Is inter-professional education the answer? Adv Health Sci Educ Theory Pract 2012; 17: 247-57